Smofkabiven 0.02 g

SMOFKABIVEN 0.02 G is an intravenous emulsion containing Tyrosine, an essential amino acid. It is used to support nutritional needs in patients requiring parenteral nutrition. This product is manufactured by Fresenius Kabi Canada Ltd.

SMOFKABIVEN 0.02 G is primarily used to provide essential amino acids, including Tyrosine, to patients who cannot obtain adequate nutrition through oral or enteral routes. It is often used in clinical settings to support patients with specific nutritional deficiencies or those undergoing medical treatments that affect nutrient absorption. This emulsion helps maintain the body's protein synthesis and overall metabolic function.

When administered intravenously, SMOFKABIVEN 0.02 G provides the body with Tyrosine, which is converted into essential compounds like dopamine, adrenaline, and thyroid hormones. Patients may experience improved nutritional status and metabolic support. However, individual responses can vary, and it is important to monitor for any adverse effects.

SMOFKABIVEN 0.02 G should be administered under medical supervision to ensure proper dosage and monitoring. Patients with known allergies to any components of the emulsion should avoid its use. It is crucial to follow proper handling and storage guidelines to maintain the integrity of the product.

SMOFKABIVEN 0.02 G may interact with other medications or supplements, particularly those that affect amino acid metabolism. Patients should inform their healthcare providers about all medications they are taking to avoid potential interactions. Additionally, it is important to consider the compatibility of this emulsion with other intravenous solutions.